HoudaBahig Profile Banner
Houda Bahig, MD PhD Profile
Houda Bahig, MD PhD

@HoudaBahig

Followers
689
Following
3K
Statuses
432

Radiation Oncologist & Clinician Scientist @chumontreal & @CRCHUM 🇨🇦 Views are my own

Montreal
Joined October 2017
Don't wanna be here? Send us removal request.
@HoudaBahig
Houda Bahig, MD PhD
14 days
RT @RTendulkarMD: Burnout & moral injury in medicine have affected so many health care workers. As a mid-career physician, here’s what I’ve…
0
98
0
@HoudaBahig
Houda Bahig, MD PhD
19 days
RT @NormandBlais: ⚠️Proud to finally have this in published format @DrRolaS @Raafatalameddin : Clinical Utility of Liquid Biopsy for the Ea…
0
4
0
@HoudaBahig
Houda Bahig, MD PhD
1 month
RT @PBlanchardMD: GORTEC announces that the NIVOPOSTOP study (NCT03576417) met its primary endpoint of Disease-Free survival (DFS) across a…
0
25
0
@HoudaBahig
Houda Bahig, MD PhD
1 month
RT @DrewMoghanaki: Look no further to learn which battlefront needs the most help. Hint: it isn’t prostate cancer.
Tweet media one
0
54
0
@HoudaBahig
Houda Bahig, MD PhD
2 months
RT @AndrearicFili: On surgery or RT after neo-adjuvant chemo-IO
0
2
0
@HoudaBahig
Houda Bahig, MD PhD
2 months
RT @CIHR_ICR: 💫 That concludes our 2024 ECR Workshop! Thanks to our partners @OICR_news and @tfri_research and our fantastic speakers for s…
0
7
0
@HoudaBahig
Houda Bahig, MD PhD
2 months
RT @CIHR_ICR: Cet après-midi, les CDC ont assisté à des séances en petits groupes sur divers sujets, comme la rédaction d’une demande de su…
0
1
0
@HoudaBahig
Houda Bahig, MD PhD
3 months
RT @StephenVLiu: Update to the @ASCO guidelines on #SCLC now @JCO_ASCO. Includes recommending durvalumab after chemoradiation for LS-SCLC b…
0
30
0
@HoudaBahig
Houda Bahig, MD PhD
3 months
RT @NormandBlais: Conférence annuelle Québécoise sur le cancer du poumon. Les détails pour l'Inscription sur l'image. @QCROC @chumontreal @…
0
1
0
@HoudaBahig
Houda Bahig, MD PhD
3 months
RT @saadvikdr: Management of Stage III Non–Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update Clinical Insights @SuyogCance
0
27
0
@HoudaBahig
Houda Bahig, MD PhD
3 months
RT @DrAlexLouie: Thanks to @StephenChunMD @AndrearicFili @samsonpp for leading our annual @IASLC #radonc webinar on controversial cases in…
0
11
0
@HoudaBahig
Houda Bahig, MD PhD
3 months
RT @_ShankarSiva: "Oligo"-no more! 🇨🇦ARREST phase I out now @IJROBP - @sueyom ➡️SABR to median=16 "poly"metastases in patients who had al…
0
79
0
@HoudaBahig
Houda Bahig, MD PhD
3 months
RT @JAMAOnc: Most viewed in the last 7 days from @JAMAOnc: In a study of over 4,500 cancer patients, those who quit smoking within 6 month…
0
35
0
@HoudaBahig
Houda Bahig, MD PhD
3 months
RT @StephenChunMD: Join @samsonpp @AndrearicFili and me for @IASLC webinar on Case Based Controversies in Locally Advanced NSCLC 11/18/2024…
0
12
0
@HoudaBahig
Houda Bahig, MD PhD
4 months
RT @ZilliThomas: Global radiotherapy demands and corresponding radiotherapy-professional workforce requirements in 2022 and predicted to 20…
0
11
0
@HoudaBahig
Houda Bahig, MD PhD
4 months
RT @DrewMoghanaki: A new publication from @max_diehn's group re-demonstrates the utility of ctDNA clearance for personalizing consolidation…
0
24
0
@HoudaBahig
Houda Bahig, MD PhD
4 months
RT @StephenVLiu: Individual patient data meta-analysis @JTOonline of neoadjuvant or perioperative trials in resectable NSCLC shows pCR or M…
0
14
0
@HoudaBahig
Houda Bahig, MD PhD
4 months
RT @StephenVLiu: Phase III trial of early thoracic radiation + TKI for #EGFR NSCLC @JCO_ASCO. Pts received oral icotinib +/- radiation (60…
0
45
0